Why Is Hims & Hers Stock (HIMS) Soaring in Pre-Market Today?

2026-03-09 10:13:04

Abstract generation in progress

Shares of Hims & Hers Health HIMS -0.88% ▼ are up over 50% in premarket trading on Monday following a Bloomberg report that Novo Nordisk NVO -1.25% ▼ plans to sell its obesity drugs through Hims & Hers’ telehealth platform as part of a new partnership. The potential deal would end a highly public feud between the two companies, which escalated into a legal battle last month. Citing a source, the report stated that the firms could announce the agreement as early as Monday.

Claim 70% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

For context, Hims & Hers Health provides accessible healthcare products and services, including prescription medications, wellness products, and online medical consultations.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.